SES AUA 2021: Contemporary Management of Advanced Prostate Cancer – Decisions Based on Precision and Better Ammunition

management of advanced prostate cancer, second line treatment of mCRPC, first line treatment for metastatic castration resistant prostate cancer, combinations of systemic therapies with or without local therapies for prostate cancer, imaging for prostate cancer, germline and somatic testing for prostate cancer, treating men with advanced prostate cancer, multidisciplinary management approaches…

Read the full article here

Related Articles